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Background: The Gene Ontology project integrates data about the function of gene products across a diverse
range of organisms, allowing the transfer of knowledge from model organisms to humans, and enabling
computational analyses for interpretation of high-throughput experimental and clinical data. The core data structure
is the annotation, an association between a gene product and a term from one of the three ontologies comprising
the GO. Historically, it has not been possible to provide additional information about the context of a GO term, such
as the target gene or the location of a molecular function. This has limited the specificity of knowledge that can be
expressed by GO annotations.
Results: The GO Consortium has introduced annotation extensions that enable manually curated GO annotations
to capture additional contextual details. Extensions represent effector–target relationships such as localization
dependencies, substrates of protein modifiers and regulation targets of signaling pathways and transcription factors
as well as spatial and temporal aspects of processes such as cell or tissue type or developmental stage. We describe
the content and structure of annotation extensions, provide examples, and summarize the current usage of
annotation extensions.
Conclusions: The additional contextual information captured by annotation extensions improves the utility of
functional annotation by representing dependencies between annotations to terms in the different ontologies of
GO, external ontologies, or an organism’s gene products. These enhanced annotations can also support
sophisticated queries and reasoning, and will provide curated, directional links between many gene products to
support pathway and network reconstruction.
Keywords: Gene Ontology, Functional annotation, Annotation extension, Manual curationBackground
Comprehensive representation of the roles of gene prod-
ucts, individually and in combination, is essential to the
understanding and modeling of biological systems. In
addition to a gene product’s intrinsic activity, aspects of
the context in which it acts, such as the gene products it
acts upon, subcellular location of the activity, distribution* Correspondence: cjmungall@lbl.gov
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unless otherwise stated.in cell or tissue types, or temporal restrictions to a cell
cycle phase or developmental stage, must be described in
order to obtain a full description of its biological role.
The Gene Ontology (GO) is a bioinformatics resource
that uses structured controlled vocabularies (ontologies)
to describe the molecular functions or activities of a gene
product, the biological processes in which a gene product
is involved and the cellular components in which a gene
product is located. Associations or ‘annotations’ can be
made between ontology terms and specific genes or gene
products using a variety of manual or algorithmic methodsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ity, for example, to support the assertion [1-4].
While the ontological rigor of the GO vocabularies has
been enriched over the years through the use of expressive
formalisms that permit logical reasoning and interaction
with external ontologies [5], the annotations themselves
have, until now, remained simple declarative statements.
Each GO annotation is essentially a pair, combining a sin-
gle gene product with a single GO term, plus supporting
metadata such as the evidence for the association [6]. Fur-
thermore, any gene product can be associated with many
GO terms, and likewise any GO term could be used to
annotate any number of gene products, the annotations
thus coded remain independent. The simplicity of this
core GO annotation model has facilitated the population
of large annotation datasets, but this simplicity has, as
well, been unable to capture the interconnections between
multiple annotations to multiple genes, resulting in limita-
tions on the granularity and connectivity of information
that could be captured. Figure 1 illustrates this by showing
a subset of Molecular Function and Cellular Component
annotations to several gene products, including micro-
somal glutathione transferase 1 [7]. While the annotations
can describe which activities the gene products can
perform, and in which components they are located, there
is no way of combining this information to convey which
activities are performed in which locations.
Guidelines for pre-composing ontology terms
In the core GO annotation model, adding new terms to
the ontology, or “pre-composing” terms, has traditionally
captured additional biological detail. However, we have set
limits on how specific terms may be differentiated from
one another. For example, generally we do not add new
terms for activities or processes that are identical apart
from which specific genes or gene products they affect.
To illustrate this, consider the two terms ‘regulation
of transcription from RNA polymerase II promoter’
(GO:0006357) and ‘regulation of Sonic hedgehog tran-
scription from RNA polymerase II promoter’. The sec-
ond term would not be added to the Biological Process
ontology because the only difference between it and its
parent is the target of the regulation; the core process
represented by the term is mechanistically no different
from analogous processes governing transcription of
other genes. Although for the purpose of understand-
ing the biology it is important to capture information
about gene products that specifically regulate the tran-
scription of Sonic hedgehog, it would not be practical
to create a specific transcription regulation term in the
Biological Process ontology for every regulation target
in a genome.
We also want to avoid pre-composing GO terms that
combine many concepts, or whose term label is verylong, making it difficult for humans to easily interpret
their meaning.
To enable curators to create flexible, meaningful GO
annotations at the time of annotation that represent a
more complete picture of gene product roles in their
biological context, we have introduced annotation exten-
sions to the GO annotation model. Curators can add detail
to GO annotations using controlled vocabularies (either
GO or external ontologies, such as Cell Type Ontology
(CL) [8]; Uber Anatomy Ontology (Uberon) [9] or Plant
Ontology (PO) [10]) and biological entities such as genes
or their products. GO annotations with extensions thus
incorporate an increased level of detail and biological inte-
gration, supporting more sophisticated querying and ana-
lysis. We have applied this model to the curation of gene
products from species such as mouse, human and fission
yeast and are proceeding to implement it throughout the
GO Consortium.
Here we describe how annotation extensions have been
incorporated into the GO annotation system, summarize
the relationship types we use for extensions, and provide
examples of how extensions can be displayed and applied,
using a corpus of annotations we have developed.
Results
Extending basic annotations with relationships
We extended the core GO annotation model to accom-
modate annotation extensions. The annotation extension
model is described formally in terms of the Web Ontology
Language (OWL) in the ‘Methods’ section. Conceptually,
we take existing GO terms such as ‘protein kinase activity’
(GO:0004672) or ‘nucleus’ (GO:0005634) and describe a
more specific subtype through the use of one or more
formal relationships to other entities (such as the protein
that is the target of the kinase, or the cell type which the
nucleus is a part of). This is logically equivalent to creat-
ing a new term for the subtype in the ontology.
An extended annotation is an annotation to a GO term
followed by one or more relational expressions (extensions).
Each relational expression is written as Relation(Entity),
where Relation is a label denoting a relationship type, and
Entity is an identifier for a database object or ontology
term. Each such expression can be thought of as refining
the core GO term used. For example, the Entity identifier
for ‘keratinocyte’ (CL:0000312) from the Cell Type Ontol-
ogy (CL) can be combined with the Relation ‘part_of ’ to
create the expression “part_of(CL:0000312)”, and when
combined with the GO term ‘nucleus’ (GO:0005634) now
describes a gene product that localizes to the nucleus of a
keratinocyte.
Relations
We created an application ontology that extends the OBO
(Open Biomedical Ontologies) Relations Ontology (RO)
Figure 1 Representation of annotations made using the core GO annotation model. Gene products can be annotated to several GO terms,
and any GO term can be used to annotate any number of gene products, but the annotations remain independent. The stars indicate an
annotation of a gene product to the GO term and each colour represents a single gene product. Using this simple GO annotation model, it is not
clear from the annotations shown in which Cellular Component each of the protein activities are performed. For example, microsomal glutathione
S-transferase 1 is represented by the red star and can perform two activities; glutathione transferase activity and glutathione peroxidase activity. It is
found in three Cellular Components, the mitochondrion, endoplasmic reticulum and peroxisomal membrane, but from these annotations the
knowledge that the glutathione transferase activity is performed in the mitochondrion [7] cannot be found. For clarity not all annotations of
each gene product are shown nor all terms between the specified terms and the root node.
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annotation extensions. These were selected and defined
for practical use by iterative discussion among curators,
and are collected in a file maintained in OBO format [12],
and also available in OWL format [13]. To enable curators
to select the appropriate relation we have created a graph-
ical web view (Figure 2; [14]), and organized relations intosubsets by entity type (for example, all relations where a
chemical entity can be specified are grouped in the
‘chemical’ subset).
The set of relations used fall into two broad categories –
molecular relations, which take an entity such as a gene,
gene product, complex or chemical as an argument; and
contextual relations, which take an entity such as a cell
ab c
Figure 2 Graphical web view of the annotation extension relations. (a) A graphical view of the relations was created to assist curators in
selecting the appropriate relation for curation [14]; (b) A user can zoom into a particular area of the graph; (c) Relations can be clicked to view
information, such as which GO terms the relation can be used with and which identifiers may be used with the relation.
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an argument. Table 1 lists the most frequently used anno-
tation extension relations with examples of their usage.
Entities
Identifiers used for the entities in annotation extensions
can reference GO or another ontology or database. Each
identifier must have a prefix found in the GO Database
Abbreviations file [15], for example “UniProtKB” (protein
database) [16], “CHEBI” (chemical database) [17], “CL”
(cell type ontology) [8], “Uberon” (metazoan anatomy
ontology) [9], or “PO” (plant anatomy ontology) [10]. A
gene product identifier used in an annotation extension,
should be interpreted in the context of the primary GO
term used. For example, the inclusion of the gene iden-
tifier SGD:S000004660 in the annotation extension field
associated with the GO term ‘protein phosphorylation’Table 1 Most commonly used relationships for annotation ex
Contextual relationships Example (gene product; primary GO term;
part_of C. elegans psf-1; nucleus; part_of(WBbt:000680
occurs_in Mouse opsin-4; G-protein coupled photorecep
happens_during S. pombe wis4; stress-activated MAPK cascade
Molecular relationships Example (gene product; primary GO term;
has_regulation_target Human suppressor of fused homolog SUFU; n
has_regulation_target(UniProtKB:P08151 zinc f
has_input S. pombe rlf2; protein localization to nucleus;
has_direct_input Human WNK4; chloride channel inhibitor activ
Molecular relations take an entity such as a gene, gene product, complex or chemic
anatomy term, developmental stage or a GO term as an argument. Entity names in
extension format.should be interpreted as “the protein product of SGD:
S000004660 is phosphorylated”.
Combining multiple extensions
In this new system, a single GO annotation can have
multiple relational expressions associated with it, where
each expression uses a single relation and a single entity.
Multiple expressions using the same relation are permitted.
For example, if a gene product can carry out its activity in
multiple locations or during various processes, multiple
Relation(Entity) pairs may be added as separate annotation
extensions.
To illustrate, consider a gene product that has its ac-
tivity in a neuron of the hippocampus. Here it would
be appropriate to make an extension combining two
expressions for both the cell type (neuron) and the
gross anatomical structure (hippocampus). If this genetension statements and examples of their usage
annotation extension)
4 body wall muscle cell)
tor activity; occurs_in(CL:0000740 retinal ganglion cell)
; happens_during(GO:0071470 cellular response to osmotic stress)
annotation extension)
egative regulation of transcription factor import into nucleus;
inger protein GLI1)
has_input(PomBase:SPAC26H5.03 pcf2)
ity; has_direct_input(UniProtKB:Q7LBE3 Solute carrier family 26 member 9)
al as an argument; contextual relations take an entity such as a cell type,
italics are shown for clarity and are not part of the annotation
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this expression could be combined in the same annotation
extension.
A description of the semantics of multiple extensions
used in the annotation extension model can be found in
the ‘Methods’ section.
Annotation extensions in curation to specify molecular
targets
Schizosaccharomyces pombe protein Nep1 illustrates
how annotation extensions can be used to represent the
multiple targets of a gene product’s enzymatic activity.
Nep1 is a protease that can deneddylate proteins modi-
fied by Nedd8 [18]. It has been shown to deneddylate
three cullin proteins, Cul1, Cul3 and Pcu4 (Figure 3a).
Using the core GO annotation model described above,a
b c
Figure 3 The deneddylation activity of S. pombe Nep1. (a) The
experimental data reported in [18] is interpreted as: Nep1 is capable
of deneddylating the cullins Cul1, Cul3 and Pcu4. (b) and (c)
Graphical representation of Nep1 annotations using (b) the core GO
annotation model and (c) the extended GO annotation model.it was not possible to record the cullins as the targets
of the deneddylation activity of Nep1. The annotation
would be:
‘NEDD8-specific protease activity’ (GO:0019784) with
the evidence code ‘Inferred from Mutant Phenotype’
(IMP) (Figure 3b).
Using annotation extensions the annotation can
be enriched as follows: Nep1 is annotated to the term
‘NEDD8-specific protease activity’ (GO:0019784) with the
evidence code IMP, and with several Relation(Entity) pairs
specifying the gene product targets of the activity:
has_direct_input(PomBase:SPAC17G6.12)|
has_direct_input(PomBase:SPAC24H6.03)|
has_direct_input(PomBase:SPAC3A11.08)
(See ‘Methods’ section for a description of the semantics
used in the annotation extension model).
This annotation means that a nep1 mutant phenotype
(IMP evidence in [18]) indicates that Nep1 executes
NEDD8-specific protease activity and can deneddylate
Cul1 (SPAC17G6.12), Cul3 (SPAC24H6.03) and Pcu4
(SPAC3A11.08) (Figure 3c). We use the relation has_dir-
ect_input here with a Molecular Function term to indicate
the effector–substrate relationship between the gene prod-
uct and its target protein. The PomBase display of the
Nep1 annotation is shown in Figure 4, note the annotation
extension relation names have been translated to more
human-readable text [19].
Annotation extensions in curation to specify locational
context
To illustrate how annotation extensions may be used to
specify locational context, we use the example of the rat
signaling complex subunit, mAKAP. mAKAP has been
shown by immunocytochemical assay to be located on
the nuclear envelope of cardiomyocytes [20].
With the core annotation model, we are only able to
capture the cellular compartment that mAKAP is located
in ‘nuclear envelope’ (GO:0005635) with the evidence code
‘Inferred from Direct Assay’ (IDA).
Using the annotation extension model as follows, we
can capture the cellular and anatomical context of the
location of mAKAP such that mAKAP is annotated to
the term ‘nuclear envelope’ (GO:0005635) with the evidence
code IDA and with two Relation(Entity) pairs specifying the
cell and tissue locations of the nuclear envelope:
part_of(CL:0002495), part_of(UBERON:0002082)
This annotation means that a direct assay (immunocyto-
chemical assay in [20]) has shown that rat mAKAP is
Figure 4 Display of annotation extension data in PomBase for S. pombe Nep1 gene product. Annotation of the observation that Nep1
deneddylates the three cullins Cul1, Cul3 and Pcu4 [18] requires one annotation with three separate expressions in the annotation extension.
Note that more human-readable text has been substituted for the annotation extension relation names for display purposes in PomBase. The
underlying data retain the relation names, and the mapping between relation names and display text is available on the PomBase website [19].
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(CL:0002495) of the ‘cardiac ventricle’ (UBERON:0002082).Table 2 Extended annotations categorized by species
Species Total no. manual
annotations
No. extended
annotations
% extended
annotations
Mus musculus 409098 25209 6.2
Homo sapiens 219258 9042 4.1
Saccharomyces
cerevisiae
53750 2713 5.0
Schizosaccharomyces
pombe
29049 1902 6.5
Caenorhabditis elegans 27488 1102 4.0
Arabidopsis thaliana 101936 503 0.5
Rattus norvegicus 72280 477 0.7
Escherichia coli 11658 426 3.7
Dictyostelium 19278 228 1.2Interconversion of core GO annotations and annotation
extensions
As annotation extensions are a relatively new feature of
GO curation, we have described and implemented methods
that allow legacy tools (i.e. those that do not have support
for extensions in their data models) to use extended
annotations without loss of specificity [21]. We have also
implemented reverse methods that allow the conversion
of basic GO annotations to extended annotations. We
informally call these methods ‘folding’ and ‘unfolding’ re-
spectively, and these make use of the OWL formalization
of the GO (see ‘Methods’ section for details). The folding
operation creates a new application ontology on the fly,
with each extended annotation materializing a new GO
term. An OWL reasoner is used to automatically con-
struct the graph in this new ontology. Application of
this method can be seen as a stopgap to allow continued
use of existing tools – the resulting application ontology,
whilst logically complete, may be unwieldy for querying
and browsing. The unfolding method takes annotations to
existing highly specific GO terms, and replaces them with
an annotation to a more basic GO term, with the equiva-
lent additional information now expressed as extensions.
Unfolding annotations is useful for reducing the complexity
of GO terms when querying or browsing.discoideum
Drosophila
melanogaster
109886 214 0.2
The number of extended annotations is shown compared to the total number
of manual annotations for each species. Calculated with the statistics from the
UniProt-GOA database [3] on 21 November 2013.Discussion
Practical application of annotation extensions
Several member groups of the GO Consortium are now
producing extended annotations to enrich their dataset.A summary of the numbers of extended annotations
categorized by species is shown in Table 2.
Currently there are few applications, databases or
browsers that make use of, or display, extended anno-
tations. In addition to their inclusion in the annotation
files, extended annotations are currently displayed in
the GO Consortium browser, AmiGO 2 [22] and on the
PomBase gene information pages [23] and there are
plans to display them in UniProt-GOA’s GO browser,
QuickGO [24], and on WormBase gene pages [25]. Outside
of the GO Consortium, Ensembl Genomes [26] now display
annotation extensions for S. pombe genes and these can be
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BioMart [27].
As extension data becomes more widely available,
querying for functional information can become more
sophisticated. Users of the GO will be able to query the
annotations for a wealth of specific information, including
connections between a gene product and other entities
and processes, or the locations — at the subcellular level
as well as cell and tissue types — where a gene product
performs specific roles. For example, a user could query
for all targets of a particular protein kinase, or compose a
more specific query to find all the proteins that are in-
volved in blood vessel remodeling during retina vascula-
ture development in the camera-type eye. Annotation
extensions capturing effector-target relationships at the
cellular level will provide a rich source of directional in-
formation for regulatory network reconstruction. For
instance, the has_input and has_direct_input relations
can be used to connect signal transducing components
of signaling pathways or to link DNA binding regulatory
transcription factors with their specific target genes.
The inherent directionality encoded in the extension can
also be used to increase the information content of existing
interaction-based networks. Annotation extensions can also
assist with improving the interpretations of pathway ana-
lysis. Currently pathway analysis, which uses methods such
as term enrichment and pathway topology, is hampered by
the lack of functional annotation with associated contextual
aspects such as cell or tissue type or dependencies on other
gene products or substances [28]. GO has the potential to
enable great advances in pathway analysis by providing this
contextual information in annotation extensions.
Pre- vs. post-composition of GO terms
As described above, increased specificity of GO annotations
has historically been achieved by adding new, more specific
ontology terms. However, new term addition cannot ac-
commodate every detail that would be desirable to capture
in GO annotations.
Using annotation extensions to increase annotation
specificity is logically equivalent to creating new terms
in the ontology (see ‘Methods’ section), but allows a
more streamlined approach for information capture at
the time of annotation. Extended annotations can be
‘folded’ to create a logical equivalent of a GO term, re-
gardless of whether the term is included in the ontology.
GO terms that are included in the ontology are said to
be ‘pre-composed’, whereas the combination of terms and
annotation extensions effectively ‘post-compose’ a term. It
is also possible to perform the inverse and ‘unfold’ pre-
composed GO terms into the equivalent extended annota-
tion expression (see ‘Methods’ section). Whether terms
are pre- or post-composed during the annotation process
is thus not critical because it is possible to interconvertseamlessly between the two. Identical information can
thus be captured by either of two routes, creation of a
new pre-composed term or during the recording of an
annotation.
Although many details captured in annotation extensions
will remain outside the scope of GO terms indefinitely, GO
developers will investigate systems by which annotation ex-
tensions can be automatically converted to pre-composed
terms when certain criteria are met, for example where a
certain number of annotations have identical extensions
and the pre-composed term is in scope. The new terms will
be added to the ontology using logical definitions that make
them equivalent to the post-compositional annotation.
Annotations made previously using post-composition can
be processed to the new pre-composed terms.
In the future, maintaining a good balance between
pre- and post-composition will be assisted by automated
methods to reason over annotations enhanced with annota-
tion extensions to ensure the annotations are consistently
grouped by an appropriate common ancestor GO term.
Impact on users of Gene Ontology annotation
The GO Consortium will provide annotation extension
data as unfolded annotations, i.e. in the annotation files,
the annotation extension will be kept in a separate field
to the primary annotation. Consumers of annotation data
can therefore choose to be unaffected by annotation ex-
tensions by simply ignoring the additional field. However,
we do hope that users and tool developers will incorporate
the extensions into their tools and workflows to provide
additional specificity to their queries and tools. For ex-
ample, a term enrichment tool provider might provide
an option to fold the annotation extensions into pre-
composed terms before a user performs term enrich-
ment. A GO browser could be extended to include an
option to search folded annotation extensions as well
as regular GO terms, e.g. it would be possible to search
for all gene products that are involved in epithelial cell
differentiation, whether or not the cell type was curated
using the specific GO term or in the annotation extension
with the more general GO term ‘cell differentiation’. A
basic query for a GO term will necessarily find the annota-
tions to that term (and its child terms) with and without
extensions, the user may choose whether or not to use the
extension data.
We encourage users and tool developers to contact us with
specific questions so we can assist them with using this data.
Future developments
A longer-term goal of the GO Consortium is to link an-
notations together to fully describe the directionality and
dependencies in a whole pathway or process. Although
annotation extensions are not sufficient to represent
complete biological pathways, they provide a valuable
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pressive annotation system is now under development
within the GO Consortium, which will allow curators
to join annotations sourced from different publications
and with different supporting evidence to describe entire
pathways or sub-processes. The annotation extensions
currently being captured will feed directly into the new
modular annotation system [29].
Conclusions
GO annotation extensions have been introduced to en-
hance the depth and utility of annotation data by capturing
specific contextual information regarding a gene product’s
function or location. Curators can now create, on-the-fly,
complex GO annotations that describe dependencies and
consequences of a gene product’s function or location more
completely than was previously possible. Data curated using
annotation extensions provides a repository for experimen-
tally verified regulation targets for a wide range of gene
products, including transcription factors and microRNAs,
information that is currently not captured by other stan-
dardized annotation approaches. A large corpus of anno-
tations now make use of annotation extensions, and this
number is growing rapidly as groups make use of powerful
curation tools such as UniProt-GOA’s Protein2GO [30].
Extensive annotation enhancement makes GO data more
informative for a biologist’s understanding of a gene or
process of interest, and provides additional value to the
data which can be used by GO analysis tool providers to
enhance the interpretation of high-throughput datasets,
such as those created by next generation sequencing, tran-
scriptomic and proteomic studies.
Methods
Annotation Extension Model
Annotation extensions are a means of dynamically referring
to subtypes of existing GO terms, by means of sets of
relation-value pairs, connected via either “and” or “or” op-
erators (represented in GO annotation files using “,” and
“|”, respectively).
We present a formal treatment of the GO annotation
extension model and the syntax used to write extensions.
This formal underpinning is necessary to clarify the seman-
tics of annotation extensions and to enable the use of auto-
mated reasoners to perform useful computations. However,
the details of the formal underpinnings can be hidden in
tools used by curators and end-users, and instead presented
in intuitive ways.
Formalization
We formalize the annotation extension model in terms of
Description Logics, and in particular the Web Ontology
Language (OWL) [31]. The GO is already heavily axioma-
tized in OWL [32]. In the core GO annotation model, anannotation is an association between a gene or gene prod-
uct G and an OWL Class C. C is restricted to be a class
from one of the three sub-ontologies of the GO: Molecu-
lar Function, Biological Process, or Cellular Component.
The meaning of the association varies depending on which
of these three sub-ontologies are used – there are a num-
ber of ways of formalizing this in OWL, however, we do
not provide details here as this is not in the scope of the
extensions provided in this manuscript.
The GO annotation extension model is formally a relax-
ation of the core model, in that it allows the annotation to
be to any OWL Class Expression that conforms to the fol-
lowing profile.
ClassExpression ::= Class | ObjectIntersectionOf
(Class RelationalExpression+)
RelationalExpression ::= ObjectSomeValuesFrom
(ObjectProperty Class)
For a description of the constructs used in the above,
please see the OWL2 syntax and semantics document [33].
The main language constructs used are (1) intersections,
which are interpreted as set-intersection (2) existential
restrictions (“some values from”) which correspond to
standard relationships such as those found in the GO
and (3) object properties, also known as relations.
It can be seen that annotation extensions form a subset
of the EL++ profile [34], which thus allows the use of fast
reasoners such as Elk [35]. This is important for the GO,
which contains large numbers of annotations.
One consequence of this model is that the external
entities, being related, must be modelled as OWL clas-
ses rather than OWL individuals. In practice this is not
a limitation, as molecular entities such as proteins are
typically modelled as classes [36].
Syntax
Annotation extensions can be expressed in a backwards
and forwards compatible extension to existing exchange
formats such as Gene Association Format (GAF); GAF
2.0 extends GAF 1.0 by providing an additional column
(position 16) in which to write a set of relational expres-
sions, as defined above. This column is optionally filled
with a disjunctive expression conforming to the following
Bachus Normal Form (BNF) grammar:
AnnotationExtension ::=
RelationalExpressionConjunction {
“|”RelationalExpressionConjunction }
RelationalExpressionConjunction ::=
RelationalExpression {“,” RelationalExpression }
RelationalExpression ::= RelationSymbol “(“ ClassID “)”
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annotations each consisting of a conjunctive expression.
The conjunctive expression is translated to an OWL
intersection expression whose elements are the main
GO class being annotated together with all relational ex-
pressions in the conjunction. Each relational expression
is translated to an OWL existential restriction (“some
values from”). The Relation Symbol is translated to an
Object Property from the Relations Ontology, and the
ClassID is translated to an OWL class, both according
to the mapping provided in the OBO format document
[37]. To precisely specify the semantics of multiple
extensions in output files, the annotation formats pro-
vided by the GO Consortium force the use of either
the comma character (“,”) or the pipe character (“|”) to
separate each expression, where the comma indicates
conjunction (AND) and the pipe indicates disjunction
(OR).
For example, an annotation to the term ‘nuclear en-
velope’ (GO:0005635) with an extension field filled
with:
part_of(CL:0002495), part_of(UBERON:0002082)
(where the CL identifier denotes cardiomyocyte and the
Uberon identifier denotes cardiac ventricle) is translated
to be an annotation to the OWL class expression:
GO_0005635 and (BFO_0000050 some CL_0002495)
and (BFO_0000050 some UBERON_0002082)
(where the BFO (Basic Formal Ontology) identifier denotes
the part_of relation).
These expressions can be used by OWL reasoners to
return guaranteed valid and complete answers to queries
such as “find all annotations to classes that are part of a
cell nucleus and part of a heart”.
The syntax does not allow nesting of expressions, but
the use of parentheses in the grammar allows for the
introduction of nesting in the future.
Property Chains
The set of object properties used can be primitive
relations (such as part_of, occurs_in or regulates) or
relations defined via an object property chain. This
effectively allows for a limited level of nesting in the
annotated OWL class expression, extending the profile
described above to:
RelationalExpression ::= ObjectSomeValuesFrom
(ObjectProperty ClassOrRelationalExpression)
ClassOrRelationalExpression ::= Class |
RelationalExpressionFor example, if a relation expression of regulates_oc-
curs_in(CL:0000540) is used, this is equivalent to an
OWL class expression
regulates some (occurs_in some CL_0000540)
Based on the definition of regulates_occurs_in < − >
regulates o occurs_in.
These chains can be expanded in user-views – for ex-
ample, AmiGO 2 will show the expression above as
“regulates . occurs_in : neuron”.
Automated validation using reasoning
We use the Elk reasoner to reason over annotation class
expressions in order to make sure they are logically co-
herent according to constraints encoded in the OWL
version of the GO, the relations ontology (RO; [11]), and
external ontologies. For example, an annotation to a
nonsense class expression that contains occurs_in some
apoptosis is flagged because the reasoner computes that
this expression is unsatisfiable, due to the constraint that
the range of occurs_in is a continuant (i.e. non-process).
We also use reasoning to automatically deepen anno-
tations to class expressions to the Most Specific Class
(MSC) in the ontology. For example, if a gene product is
annotated to ‘postsynaptic density’ (GO:0014069) and has
the extension field filled with “part_of(CL:0000127)”, this
is directly translated to the class expression ‘postsynaptic
density’ and part_of some astrocyte which is inferred to
have the MSC GO:0097483 (‘glial cell postsynaptic dens-
ity’) based on equivalence axioms in the GO [5]: ‘glial cell
postsynaptic density’ EquivalentTo ‘postsynaptic dens-
ity’ and part_of some ‘glial cell’ and the axiom ‘astro-
cyte’ SubClassOf ‘glial cell’ inferred from the Cell Type
Ontology.
These reasoner checks and deepening procedures are
performed by the GO Continuous Integration server [38].
We translate Gene Association Files into OWL using
OWLTools [39].
Annotation folding and unfolding procedure
We define a process of annotation folding that takes as
input the GO plus a set of supporting ontologies together
with a set of extended annotations and generates as out-
put an additional ontology plus a set of basic annotations,
where the input and output are logically equivalent [21].
For each extended annotation a to a term t and extension
expression e, we replace this with an annotation a’ to a
term tA, where tA is added to the application ontology,
with an equivalence axiom tA EquivalentTo (t and e). A
fast OWL reasoner such as Elk is used to automatically
classify the application ontology. The completeness of the
classification is related to the proportion of classes in the
core GO ontology that have equivalence axioms.
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as input the GO plus a set of supporting ontologies
together with a set of basic annotations and generates as
output a simplified GO plus a set of extended annotations.
For each annotation a to a term t, if the term t has an
equivalence axiom in the GO to an expression (t’ and e),
where t’ is a GO term and e conforms to an extension
expression, then replace a with a new annotation a’,
where t is replaced by t’ and the extension field is filled
with e.Curation procedures
Annotation extensions are created as part of the manual
curation process [6]. This involves biological database
curators reading full text, peer-reviewed articles to obtain
information about gene product functions, the processes
in which they are involved and their subcellular locations
[1-4]. Curators choose GO terms that describe these
aspects of a gene product and assign an evidence code
that is appropriate for the type of supporting experiment
or statement in the paper. The GO annotations and any
annotation extension information are entered into the
annotating groups’ curation tool for inclusion in their
database and/or display on their website. On a periodic
basis, each group submits their file(s) of annotations
for display on the GO Consortium website [40] and ftp
site [41].
Annotation extensions are formatted as Relation
(Entity) – where ‘Entity’ is an identifier in an ontology or
database, expressed as ‘DB:ID’ – in the current GO anno-
tation file format (GAF2.0, column 16) [42] and in the
new format Gene Product Association Data (GPAD, col-
umn 11) [43]. The DB prefix must be listed in the GO
Database Abbreviations collection [15].Data availability and resources
Annotation extensions can be represented in the two
GO Consortium-supported annotation formats, GAF 2.0
[42] and GPAD [43]. These files are housed on the Gene
Ontology Consortium website [40].
Annotation extension data is available in AmiGO2
[22] and for S. pombe genes is additionally displayed on
the PomBase gene pages [44] and in the Ensembl Fungi
BioMart [27].
Further documentation on annotation extensions can
be found on the GO Consortium website [45].Abbreviations
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